Ajit Ramalingam - Sep 1, 2021 Form 4 Insider Report for BIO-RAD LABORATORIES, INC. (BIO)

Role: SVP, Chief Accounting Officer
Signature: /s/ Ajit Ramalingam
Stock symbol: BIO
Transactions as of: Sep 1, 2021
Transactions value $: -$68,539
Form type: 4
Date filed: 9/3/2021, 05:07 PM
Next filing: May 2, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BIO	Bio-Rad A Common Stock	Options Exercise	$0	+240	+102.83%	$0.00	473	Sep 2, 2021	Direct	F1, F2
transaction	BIO	Bio-Rad A Common Stock	Tax liability	-$68.5K	-83	-17.53%	$825.77	390	Sep 2, 2021	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BIO	Restricted Stock Units	Award	$0	+676		$0.00	676	Sep 1, 2021	Bio-Rad A Common Stock	676	$0.00	Direct	F3, F4
transaction	BIO	Restricted Stock Units	Options Exercise	$0	-240	-24.92%	$0.00	723	Sep 2, 2021	Bio-Rad A Common Stock	240	$0.00	Direct	F3, F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares of Class A common stock acquired on the vesting of restricted stock units.
F2	Includes 11.7355 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 06/30/2021.
F3	Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
F4	The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant.
F5	On September 2, 2020, the reporting person was granted 963 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.